跳至主要内容
临床试验/IRCT20221126056611N1
IRCT20221126056611N1已完成3 期

Aspirin administration from early pregnancy versus initiation after 11 week’s gestations, for prevention of pre-eclampsia in high-risk pregnant women.

Tehran University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • The participants are pregnant women at high-risk for preeclampsia based on demographic characteristics and personal and obstetrics history, according to the ACOG and USPSTF and SMFM guidelines.

排除标准

  • 1)Hypersensitivity to nonsteroidal anti-inflammatory drug products
  • 2)Asthma-rhinitis and nasal polyps
  • 3)Sever renal or sever hepatic impairment.
  • 4)History of gastrointestinal bleeding or active peptic ulcer disease
  • 5)vaginal bleeding or significant hematoma on ultrasound.
  • 6)gestational age > 16 week

研究者

相似试验